Linked Life Data

11095579

Source:http://linkedlifedata.com/resource/pubmed/id/11095579

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2001-2-2
pubmed:abstractText
This article is a report on a symposium sponsored by the American Society for Pharmacology and Experimental Therapeutics presented at the joint meeting of the American Society for Biochemistry and Molecular Biology and the American Society for Pharmacology and Experimental Therapeutics, June 4-8, Boston, Massachusetts. The presentations focused on the pharmacogenetics of the NAT1 and NAT2 arylamine N-acetyltransferases, including developmental regulation, structure-function relationships, and their possible role in susceptibility to breast, colon, and pancreatic cancers. The symposium honored Wendell W. Weber for over 35 years of leadership and scientific advancement in pharmacogenetics and was highlighted by his overview of the historical development of the field.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0090-9556
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1425-32
pubmed:dateRevised
2008-1-17
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Pharmacogenetics of the arylamine N-acetyltransferases: a symposium in honor of Wendell W. Weber.
pubmed:affiliation
Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, Kentucky, USA. d.hein@louisville.edu
pubmed:publicationType
Research Support, U.S. Gov't, P.H.S., Congresses, Research Support, Non-U.S. Gov't